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Introduction
Pain severity is an important symptom 
to assess for in head and neck cancer 
patients undergoing radiotherapy (RT) 
due to its effects on the quality of life 
[1]. Although radiation itself is painless, 
it induces an acute postradiation
reaction that can cause many side 
effects, with the most debilitating being 
oral mucositis [2]. Studies have shown 
a correlation between severity of pain 
and severity of oral mucositis [3]. To 
help manage the pain, the World 
Health Organization (WHO) has a 
recommended escalation chain of 
analgesics guideline, starting with 
NSAIDS, then weak opioids, followed 
by potent opioids [4]. Due to the 
subjective nature of pain, which can be 
difficult for health systems to measure, 
patient reported outcome measures 
(PROMs) is a tool that can be used to 
better gauge and improve patient’s 
health experience [5]. Significant pain 
signals that modifications in pain 
management are needed to better 
monitor the pain. In this study, we used 
an institution-based PROM, The MD 
Anderson Symptom Inventory 
(MDASI), for pain assessment. The 
objective of our project is to determine 
the efficacy of pain management 
during RT using PROM.
Methods
Retrospective data was obtained for 
500 oral cavity and oropharyngeal 
(OC/OPC) cancer patients, treated 
with RT at theRadiation Oncology 
department, MD Anderson Cancer 
Center in Houston, TX, USA. Pain 
scores were collected during the 
weekly see visits using MDASI, 
which is a multi-symptom PROM 
used to assess the severity of 
symptoms and how much of that 
disrupts daily life [6], using a scale 
from 0 to 10 (0 = no pain, 10=the 
worst pain). Clinical data was 
collected using EPIC and Brocade 
software. Pain scores were 
compared to mucositis intensity (0 
=none, 1 =mild, 2 =moderate, 3 
=severe), assessed weekly during 
radiation therapy visits. Patients 
were divided into cohorts based on 
age (19-33 =1, 34-48 =2, 49-64 =3, 
65-78 =4, 79-98 =5). T-test and 
ANOVA test were used for 
statistical analysis.
Results
MDASI pain scores reported 
during weekly see visits 
revealed a significant increase 
through the course of RT (p 
<0.0001), with the highest 
severity of pain is experienced 
at the end of RT. Pain scores 
were tested across age groups. 
There were no significant 
differences in pain scores 
between age cohorts, with a 
similar trend in each week 
across the cohorts.
Conclusions
The aim of this study is to 
determine the efficacy of pain 
management during radiation 
therapy using PROM. Our data 
suggests that pain levels 
consistently increased during 
RT. This suggests the pain 
management currently 
implemented may not 
adequately control pain during 
the weeks of RT and may be in 
need for improvement. This is 
important to address due to the 
negative effect pain can have on 
the quality of life [1]. 
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Future steps to take can include analyzing which 
types of analgesics are given and at what point 
during radiation therapy. Stronger pain medications 
may be needed earlier during the course to prevent 
high levels of pain seen towards the end of radiation 
therapy. By analyzing pain scores alongside the type 
and when analgesics are administered, this opens 
the possibility for modification of the current pain 
management plan, improving the patient’s overall 
quality of life and experience. 
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Fig. 1 Pain scores were compared to mucositis severity 
(0 =none, 1 =mild, 2 =moderate, 3 =severe), assessed 
weekly during radiation therapy visits.
Fig. 2 MDASI pain scores and 
mucositis severity displayed a 
significant difference from week 1 to 






























Fig. 3 MDASI pain scores measured 
across weeks 1 to 7 for 5 age 
cohorts. Patients were divided into 
cohorts based on age (19-33 =1, 34-
48 =2, 49-64 =3, 65-78 =4, 79-98 
=5).
Fig. 4 Collected the types of analgesics administered (based 
on the WHO analgesics ladder) to 224 out of the 500 patients 
during the course of RT. 0=no and 1=yes. The mean values for 
each analgesic is displayed. 
Diagram 1 Overall 
Schematic of main 
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